London, United Kingdom

Tina Lesley Crombie

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Cell Medica Limited. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tina Lesley Crombie. Retrieved from https://idiyas.com/inventor/tina-lesley-crombie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tina Lesley Crombie - Pioneering Inventor from London, GB

Introduction: Tina Lesley Crombie is a renowned inventor based in London, GB, known for her groundbreaking contributions to various industries through her innovative creations.

Latest Patents: Tina Lesley Crombie holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing her diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Tina Lesley Crombie has established herself as a leading figure in the world of inventions, with numerous successful products launched under her name.

Collaborations: Throughout her career, Tina Lesley Crombie has collaborated with top research institutions, universities, and companies to bring her ideas to life, fostering a culture of innovation and creativity in her projects.

Conclusion: Tina Lesley Crombie's passion for innovation and her relentless drive to push the boundaries of what is possible make her a true trailblazer in the world of inventions, inspiring future generations of inventors to dream big and create change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…